Latest News
RHYTHM AI Announces Clinical Trial Collaboration With Biosense Webster
RHYTHM AI Announces Clinical Trial Collaboration With Biosense Webster Companies to collaborate on multi-centre study of STAR Mapping™ to improve outcomes of persistent Atrial Fibrillation treatment [...]
HRC 2019: Sequential approach using STAR mapping system identifies key early sites of activation in patients with persistent AF
HRC 2019: Sequential approach using STAR mapping system identifies key early sites of activation in patients with persistent AF The use of a Stochastic Trajectory Analysis [...]
RHYTHM AI Successfully Closes Seed Financing Round
Proceeds to fund multi-centre study of STAR Mapping™ to improve outcomes of persistent Atrial Fibrillation treatment London, UK- 10 September 2019: RHYTHM AI Ltd ("RHYTHM AI" [...]
STAR Mapping Outcome Study in AF
RHYTHM AI Ltd Announces publication of Human Clinical Outcome Study for STAR Mapping™ System for Treatment of Persistent Atrial Fibrillation 80% of patients treated for persistent [...]
STAR Mapping Licence Agreement
RHYTHM AI Ltd and Barts NHS Trust enter into an Exclusive Worldwide Licence Agreement for STAR Mapping™ Technology for Treatment of Atrial Fibrillation Oxford, UK- April [...]
Research Paper on Ablation in Persistent AF using STAR Mapping™
Research Paper on Ablation in Persistent AF using STAR Mapping™ Ablation in Persistent Atrial Fibrillation Using Stochastic Trajectory Analysis of Ranked Signals (STAR) Mapping Method [...]